Kukovetz W R, Brunner F, Beubler E, Weyhenmeyer R, Lohaus R, Grob M, Mayer D
Eur J Drug Metab Pharmacokinet. 1982;7(2):105-10. doi: 10.1007/BF03188726.
Fendiline was administered intravenously (3 mg) and orally (50 mg and 75 mg) in a cross-over study to six healthy volunteers. The plasma levels of unchanged fendiline and of total radioactivity were measured. Fendiline was absorbed well and its concentration declined biexponentially with mean terminal half-lives of 20-35 h. Since the drug is extensively metabolized, only 12% of total radioactivity in plasma corresponded to fendiline in the case of intravenous administration as compared to less than 2% after oral administration. 56-65% of the administered dose are excreted via the urine and 18-25% with the feces within five days.
在一项交叉研究中,对6名健康志愿者静脉注射(3毫克)和口服(50毫克和75毫克)芬地林。测定了未变化的芬地林血浆水平和总放射性。芬地林吸收良好,其浓度呈双指数下降,平均终末半衰期为20 - 35小时。由于该药物广泛代谢,静脉给药时血浆中总放射性的12%对应于芬地林,而口服给药后这一比例不到2%。给药剂量的56 - 65%在五天内通过尿液排泄,18 - 25%通过粪便排泄。